These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 23795859

  • 1. What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?
    Samalin L, Nourry A, Charpeaud T, Llorca PM.
    Nord J Psychiatry; 2014 May; 68(4):227-35. PubMed ID: 23795859
    [Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
    Wu CS, Hsieh MH, Tang CH, Chang CJ.
    J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437
    [Abstract] [Full Text] [Related]

  • 3. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.
    Gigante AD, Lafer B, Yatham LN.
    CNS Drugs; 2012 May 01; 26(5):403-20. PubMed ID: 22494448
    [Abstract] [Full Text] [Related]

  • 4. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L, Abbar M, Courtet P, Guillaume S, Lancrenon S, Llorca PM.
    Encephale; 2013 Dec 01; 39 Suppl 4():189-203. PubMed ID: 24373464
    [Abstract] [Full Text] [Related]

  • 5. Long-acting second-generation injectable antipsychotics for the maintenance treatment of bipolar disorder: a narrative review.
    Belge JB, Sabbe BGCC.
    Expert Opin Pharmacother; 2024 Feb 01; 25(3):295-299. PubMed ID: 38465894
    [Abstract] [Full Text] [Related]

  • 6. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
    Keramatian K, Chakrabarty T, Yatham LN.
    CNS Drugs; 2019 May 01; 33(5):431-456. PubMed ID: 30963507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.
    Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E.
    Eur Neuropsychopharmacol; 2019 Apr 01; 29(4):457-470. PubMed ID: 30770235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Depot antipsychotic medications in bipolar disorder: a review of the literature.
    Bond DJ, Pratoomsri W, Yatham LN.
    Acta Psychiatr Scand Suppl; 2007 Apr 01; (434):3-16. PubMed ID: 17688458
    [Abstract] [Full Text] [Related]

  • 13. Adherence and assured administration of medications in bipolar patients.
    El-Mallakh PL, El-Mallakh RS.
    Curr Drug Deliv; 2013 Dec 01; 10(6):706-12. PubMed ID: 24033263
    [Abstract] [Full Text] [Related]

  • 14. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Malempati RN, Bond DJ, Yatham LN.
    Int Clin Psychopharmacol; 2008 Mar 01; 23(2):88-94. PubMed ID: 18301123
    [Abstract] [Full Text] [Related]

  • 15. Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection.
    Samalin L, Charpeaud T, Lorabi O, Llorca P.
    Patient Prefer Adherence; 2010 Sep 07; 4():325-34. PubMed ID: 20859459
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risperidone long-acting injection: in bipolar I disorder.
    Deeks ED.
    Drugs; 2010 May 28; 70(8):1001-12. PubMed ID: 20481656
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis.
    Prajapati AR, Wilson J, Maidment I.
    BMJ Open; 2016 Jan 06; 6(1):e010237. PubMed ID: 26739743
    [Abstract] [Full Text] [Related]

  • 19. Atypical presentation of tardive dyskinesia associated with risperidone long-acting injection as maintenance treatment in bipolar affective disorder: a case report.
    Chung AK.
    Curr Drug Saf; 2012 Feb 06; 7(1):21-3. PubMed ID: 22663952
    [Abstract] [Full Text] [Related]

  • 20. Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence.
    Boyce P, Irwin L, Morris G, Hamilton A, Mulder R, Malhi GS, Porter RJ.
    Bipolar Disord; 2018 Nov 06; 20 Suppl 2():25-36. PubMed ID: 30328222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.